Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

tumor marker

(TOO-mer MAR-ker)
A substance found in tissue, blood, bone marrow, or other body fluids that may be a sign of cancer or certain benign (noncancer) conditions. Many tumor markers are proteins made by both normal cells and cancer cells, but they are made in higher amounts by cancer cells. Genetic changes in tumor tissue, such as gene mutations, patterns of gene expression, and other changes in tumor DNA or RNA, are also being used as tumor markers. A tumor marker may be used with other tests to help diagnose cancer. It may also be used to help plan treatment, give a likely prognosis, and find out how well treatment is working or if cancer has come back. Examples of tumor markers include CA-125 (in ovarian cancer), estrogen receptor and progesterone receptor (in breast cancer), CEA (in colon cancer), PCA3 mRNA and PSA (in prostate cancer), and EGFR gene mutation (in non-small cell lung cancer).
Search NCI's Dictionary of Cancer Terms